We are analyzing https://link.springer.com/article/10.1007/bf00944177.

Title:
Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria | Investigational New Drugs
Description:
The Southwest Oncology Group, in cooperation with the National Cancer Institute and the other major cooperative oncology groups, has participated in the development of new toxicity criteria for reporting the results of cancer clinical trials. The new criteria (NCI Common Toxicity Criteria) respond to a recognized need to: (1) report toxicities consistently among cooperative groups, particularly for shared ‘intergroup’ clinical trials; (2) strive for comparability in toxicity reporting among clinical trials; and (3) recognize new toxicities accompanying new classes of anticancer treatment modalities. The Southwest Oncology Group has extended the toxicity criteria, incorporating additional new criteria for biological agents, radiation therapy, surgery, and hormonal agents. In addition, endpoint definitions and response criteria are discussed. These have been developed in response to previous uncertainties in clinical trials objectives, to limitations in the resolution of imaging methods, and to demands for greater rigor in response and endpoint definitions. Toxicity criteria, endpoint definitions, and response criteria are tabulated.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Non-Profit & Charity
Telecommunications
Social Networks

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

criteria, oncology, article, response, toxicity, group, clinical, trials, privacy, cookies, content, southwest, endpoint, definitions, cancer, publish, search, access, chapter, data, information, log, journal, research, drugs, green, weiss, cooperative, portfolio, discover, usa, springer, optional, personal, parties, standards, policy, find, track, investigational, standard, cite, stephanie, geoffrey, explore, groups, reporting, toxicities, treatment, agents,

Topics {✒️}

cancer clinical trials month download article/chapter southwest oncology group national cancer institute clinical trials objectives related subjects medical oncology privacy choices/manage cookies clinical trials toxicity criteria published treatment response assessment full article pdf varying standards european economic area anticancer treatment modalities conditions privacy policy report toxicities consistently cooperative groups accepting optional cookies response criteria article green journal finder publish toxicity criteria check access instant access article investigational weiss rights usa geoffrey privacy policy article log personal data drugs aims books a optional cookies information manage preferences toxicity reporting article cite subscription content similar content data protection essential cookies cookies skip toxicities accompanying institution subscribe journal publish response usage analysis social media endpoint definitions

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria
         description:The Southwest Oncology Group, in cooperation with the National Cancer Institute and the other major cooperative oncology groups, has participated in the development of new toxicity criteria for reporting the results of cancer clinical trials. The new criteria (NCI Common Toxicity Criteria) respond to a recognized need to: (1) report toxicities consistently among cooperative groups, particularly for shared ‘intergroup’ clinical trials; (2) strive for comparability in toxicity reporting among clinical trials; and (3) recognize new toxicities accompanying new classes of anticancer treatment modalities. The Southwest Oncology Group has extended the toxicity criteria, incorporating additional new criteria for biological agents, radiation therapy, surgery, and hormonal agents. In addition, endpoint definitions and response criteria are discussed. These have been developed in response to previous uncertainties in clinical trials objectives, to limitations in the resolution of imaging methods, and to demands for greater rigor in response and endpoint definitions. Toxicity criteria, endpoint definitions, and response criteria are tabulated.
         datePublished:
         dateModified:
         pageStart:239
         pageEnd:253
         sameAs:https://doi.org/10.1007/BF00944177
         keywords:
            cooperative group
            toxicity criteria
            response criteria
            Oncology
            Pharmacology/Toxicology
         image:
         isPartOf:
            name:Investigational New Drugs
            issn:
               1573-0646
               0167-6997
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Stephanie Green
               affiliation:
                     name:Southwest Oncology Group Statistical Center
                     address:
                        name:Southwest Oncology Group Statistical Center, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Geoffrey R. Weiss
               affiliation:
                     name:The University of Texas Health Science Center at San Antonio
                     address:
                        name:Department of Medicine, Division of Medical Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria
      description:The Southwest Oncology Group, in cooperation with the National Cancer Institute and the other major cooperative oncology groups, has participated in the development of new toxicity criteria for reporting the results of cancer clinical trials. The new criteria (NCI Common Toxicity Criteria) respond to a recognized need to: (1) report toxicities consistently among cooperative groups, particularly for shared ‘intergroup’ clinical trials; (2) strive for comparability in toxicity reporting among clinical trials; and (3) recognize new toxicities accompanying new classes of anticancer treatment modalities. The Southwest Oncology Group has extended the toxicity criteria, incorporating additional new criteria for biological agents, radiation therapy, surgery, and hormonal agents. In addition, endpoint definitions and response criteria are discussed. These have been developed in response to previous uncertainties in clinical trials objectives, to limitations in the resolution of imaging methods, and to demands for greater rigor in response and endpoint definitions. Toxicity criteria, endpoint definitions, and response criteria are tabulated.
      datePublished:
      dateModified:
      pageStart:239
      pageEnd:253
      sameAs:https://doi.org/10.1007/BF00944177
      keywords:
         cooperative group
         toxicity criteria
         response criteria
         Oncology
         Pharmacology/Toxicology
      image:
      isPartOf:
         name:Investigational New Drugs
         issn:
            1573-0646
            0167-6997
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Stephanie Green
            affiliation:
                  name:Southwest Oncology Group Statistical Center
                  address:
                     name:Southwest Oncology Group Statistical Center, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Geoffrey R. Weiss
            affiliation:
                  name:The University of Texas Health Science Center at San Antonio
                  address:
                     name:Department of Medicine, Division of Medical Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Investigational New Drugs
      issn:
         1573-0646
         0167-6997
      volumeNumber:10
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Southwest Oncology Group Statistical Center
      address:
         name:Southwest Oncology Group Statistical Center, Seattle, USA
         type:PostalAddress
      name:The University of Texas Health Science Center at San Antonio
      address:
         name:Department of Medicine, Division of Medical Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Stephanie Green
      affiliation:
            name:Southwest Oncology Group Statistical Center
            address:
               name:Southwest Oncology Group Statistical Center, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Geoffrey R. Weiss
      affiliation:
            name:The University of Texas Health Science Center at San Antonio
            address:
               name:Department of Medicine, Division of Medical Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Southwest Oncology Group Statistical Center, Seattle, USA
      name:Department of Medicine, Division of Medical Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(27)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.71s.

LINK . SPRINGER . COM {}